Abstract
Why do people with type 1 diabetes have such difficulty achieving euglycaemia? An inverse association exists between reductions in hyperglycaemia and increasing hypoglycaemia: as patients approach euglycaemia, the key factor preventing further improvement is hypoglycaemia. Even mild hypoglycaemia is associated with reductions in quality of life. Management of glycaemia in type 1 diabetes therefore entails more than preventing increases in glucose and correcting hyperglycaemia promptly when it occurs; it is also critical to prevent hypoglycaemia.
| Original language | English |
|---|---|
| Pages (from-to) | 190-191 |
| Number of pages | 2 |
| Journal | The Lancet Diabetes and Endocrinology |
| Volume | 4 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- diabetes
- glucagon-like peptide 1
- glucose
- hyperglycaemia
- hypoglycaemia
- insulin
Fingerprint
Dive into the research topics of 'Use of liraglutide in type 1 diabetes : implications for management'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver